ASMPT (00522) disclosed that, on 5 May 2026, a total of 1,517,300 new shares—equivalent to 0.36 % of the company’s 417,836,983 issued shares—were granted to 1,073 employees through the employee share incentive scheme adopted on 24 March 2020. No director, chief executive, substantial shareholder or their associates were included in the award.

The award is split into two tranches:

1) 1,184,600 shares allocated to 1,059 staff carry no purchase price and will vest on 15 December 2026. The vesting period is shorter than 12 months because the allocation is based on performance in the preceding year. No performance targets or clawback clauses apply.

2) 332,700 shares granted to 14 employees comprise 193,700 performance-based shares and 139,000 retention-based shares. • Performance-based shares will vest on 2 May 2029, contingent upon ASMPT’s revenue growth and EBIT margin versus industry peers for 2026-2028; if threshold performance is not met, none will vest. • Retention-based shares will vest in three tranches: 50 % on 3 May 2027, 25 % on 3 May 2028, and 25 % on 2 May 2029. • A clawback mechanism allows reclamation of accelerated-vesting shares if post-employment obligations are breached.

Based on the HK$163.30 closing price on the award date, the market value of the 1.52 million shares is approximately HK$247.78 million.

For employees who are not connected persons at vesting, the shares will be satisfied by new share issuance at par; for connected persons, the scheme trustee will purchase shares in the market. After this allocation, 24,040,233 shares remain available for future grants under the scheme limit.

The scheme predates the revised Chapter 17 of the Listing Rules; ASMPT will apply transitional provisions to ensure compliance going forward.